(Q33374059)

English

Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

object named as

Elke Jäger

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Salah-Eddin Al-Batran

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Anne Kerber

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Akin Atmaca

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Claudius Dechow

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ernst Reitsamer

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sebastian Schmidt

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yvonne Kolassa

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Antje Neumann

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eckhart Weidmann

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Joerg Thomas Hartmann

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

26 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

29-34

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A systematic overview of chemotherapy effects in gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Cellular and molecular aspects of drugs of the future: oxaliplatin.

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Infusional 5-fluorouracil and mitomycin C: an effective regimen in the treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Oxaliplatin (L-OHP): a new reality in colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1159%2F000097768

21 January 2018

Identifiers

10.1159/000097768

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

release_p2vzm3ib4fe6hlcmm2rzjsarge

1 reference

https://api.fatcat.wiki/v0/release/p2vzm3ib4fe6hlcmm2rzjsarge

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33374059&oldid=1837079362"